BIO-Key International Inc

Industrials US BKYI

0.771297USD
-0.0387(4.78%)

Last update at 2025-06-13T16:41:00Z

Day Range

0.760.81
LowHigh

52 Week Range

1.4814.40
LowHigh

Fundamentals

  • Previous Close 0.81
  • Market Cap3.40M
  • Volume229944
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-5.06396M
  • Revenue TTM8.59M
  • Revenue Per Share TTM17.48
  • Gross Profit TTM 3.44M
  • Diluted EPS TTM-19.41

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -10.23144M -5.06578M -9.67399M -14.58870M -6.86888M
Minority interest - - - - -
Net income -10.74271M -4.56971M -13.59029M -14.65298M -6.86888M
Selling general administrative 9.64M 6.03M 5.85M 5.04M 5.33M
Selling and marketing expenses - - - - -
Gross profit 4.98M 3.44M 2.04M -0.19372M -0.11965M
Reconciled depreciation 0.55M 0.51M 0.43M 1.00M 1.61M
Ebit -9.69023M -5.00186M -4.86235M -6.56220M -6.86895M
Ebitda -8.36634M -4.99778M -4.83170M -6.56205M -5.25551M
Depreciation and amortization 1.32M 0.00407M 0.03M 0.00015M 1.61M
Non operating income net other - - -5.20317M -6.56220M -
Operating income -9.69023M -5.00186M -4.86235M -6.56220M -6.86895M
Other operating expenses 15.39M 10.12M 7.70M 8.83M 10.91M
Interest expense 0.03M 0.02M 4.34M 1.07M 0.00008M
Tax provision -0.02043M - - - -
Interest income 0.00023M 0.00407M 0.03M 0.00015M 0.00008M
Net interest income -0.02972M -0.01392M -4.31256M -1.06898M 0.00008M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.51M -0.49607M 3.92M 0.06M 0.00016M
Total revenue 7.02M 5.11M 2.84M 2.27M 4.04M
Total operating expenses 13.35M 8.44M 6.90M 6.37M 6.75M
Cost of revenue 2.04M 1.67M 0.79M 2.46M 4.16M
Total other income expense net -0.54122M -0.06392M -4.81164M -8.02650M 0.00008M
Discontinued operations - - - - -
Net income from continuing ops -10.23144M -5.06578M -9.67399M -14.58870M -6.86888M
Net income applicable to common shares - -5.06578M -9.78667M -14.58870M -8.49587M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets - 11.91M 17.77M 22.52M 2.50M
Intangible assets - 1.80M 1.35M 1.57M 0.23M
Earning assets - - - - -
Other current assets - 0.33M 0.22M 0.20M 0.11M
Total liab - 4.85M 2.19M 2.19M 4.78M
Total stockholder equity - 7.06M 15.58M 20.34M -2.28517M
Deferred long term liab - - 0.25M 0.17M 0.23M
Other current liab - 1.01M 0.87M 0.51M 0.69M
Common stock - 0.00092M 0.00079M 0.00078M 0.00144M
Capital stock - 0.00092M 0.00079M 0.00078M 0.00144M
Retained earnings - -114.80691M -104.57547M -99.50969M -89.72302M
Other liab - - 0.07M 0.04M -
Good will - 0.00000M 1.26M 1.26M -
Other assets - - 0.37M 0.17M 0.24M
Cash - 2.64M 7.75M 16.99M 0.08M
Cash and equivalents - - - - -
Total current liabilities - 4.64M 2.04M 1.88M 4.39M
Current deferred revenue - 0.46M 0.57M 0.66M 0.36M
Net debt - -0.41409M -7.48988M -16.26262M 2.74M
Short term debt - 2.06M 0.18M 0.47M 2.43M
Short long term debt - 1.90M - 0.23M 2.26M
Short long term debt total - 2.22M 0.26M 0.73M 2.82M
Other stockholder equity - 122.11M 120.15M 119.84M 87.44M
Property plant equipment - - 0.32M 0.57M 0.66M
Total current assets - 9.37M 14.01M 18.94M 1.37M
Long term investments - 0.00000M 0.45M - -
Net tangible assets - - 12.97M 17.50M -2.51336M
Short term investments - - 0.00000M 0.51M 0.51M
Net receivables - 1.57M 1.10M 0.90M 0.24M
Long term debt - 0.12M - - -
Inventory - 4.83M 4.94M 0.33M 0.43M
Accounts payable - 1.11M 0.43M 0.24M 0.92M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - -0.24260M - - -0.77230M
Additional paid in capital - - - - -
Common stock total equity - - - 0.00078M 0.00144M
Preferred stock total equity - - - - -
Retained earnings total equity - - - -99.50969M -89.72302M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.44M 0.37M 0.17M 0.24M
Deferred long term asset charges - - - - -
Non current assets total - 2.54M 3.76M 3.58M 1.13M
Capital lease obligations - 0.20M 0.26M 0.50M 0.56M
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.69662M -0.04202M -2.22982M -0.51282M -0.08246M
Change to liabilities - 0.11M -0.84728M 0.74M -0.46901M
Total cashflows from investing activities - -0.04202M -2.22982M -0.54331M -0.08246M
Net borrowings - -0.25000M -0.98999M 2.51M 2.51M
Total cash from financing activities 1.90M -0.21860M 24.09M 2.15M 1.73M
Change to operating activities - -0.12271M -0.44394M 0.13M 0.80M
Net income -11.90990M -5.06578M -9.67399M -14.58870M -6.86888M
Change in cash -5.11852M -9.23905M 16.91M -0.24493M 0.04M
Begin period cash flow 7.75M 16.99M 0.08M 0.32M 0.29M
End period cash flow 2.64M 7.75M 16.99M 0.08M 0.32M
Total cash from operating activities -6.22903M -8.97843M -4.95011M -1.85035M -1.61347M
Issuance of capital stock - 0.00000M 22.17M 0.00000M 1.88M
Depreciation 0.55M 0.51M 0.43M 1.00M 1.61M
Other cashflows from investing activities - - -0.29500M -0.00174M -0.03040M
Dividends paid - - - - -
Change to inventory 0.11M -4.60971M 0.10M 0.57M -0.05198M
Change to account receivables -0.33938M -0.67258M -0.23726M 0.88M 1.34M
Sale purchase of stock - - 25.08M -0.36127M 1.73M
Other cashflows from financing activities 1.90M 0.03M 6.87M 2.86M -0.14394M
Change to netincome - 0.72M 1.29M 7.52M 1.66M
Capital expenditures 0.08M 0.04M 0.04M 0.03M 0.08M
Change receivables - - -0.18677M 0.83M 1.40M
Cash flows other operating - - 1.45M 1.96M 2.62M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - 16.91M -0.24493M 0.04M
Change in working capital -0.29902M -5.28012M -1.37982M 2.13M 1.82M
Stock based compensation 0.39M 0.31M 0.79M 0.95M 0.98M
Other non cash items 5.07M 0.13M 4.39M 1.13M 0.12M
Free cash flow -6.31107M -9.02045M -4.98568M -1.88084M -1.69593M

Peer Comparison

Sector: Industrials Industry: Security & Protection Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
BKYI
BIO-Key International Inc
-0.0387 4.78% 0.77 - - 0.39 1.00 0.67 -0.6925
ASAZF
ASSA ABLOY AB (publ)
- -% 31.86 24.30 22.68 0.24 3.69 3.06 14.88
ASAZY
Assa Abloy AB
-0.15 0.93% 15.95 24.87 23.20 0.24 3.78 3.06 14.88
SOMLY
Secom Co Ltd ADR
- -% 9.29 21.35 - 0.01 1.79 0.0097 0.05
SOMLF
SECOM CO. LTD
- -% 38.19 20.94 - 0.01 1.80 0.0076 0.05

Reports Covered

Stock Research & News

Profile

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.

BIO-Key International Inc

Building A, Wall, NJ, United States, 07719

Key Executives

Name Title Year Born
Mr. Michael W. DePasquale Chairman & CEO 1955
Ms. Mira K. LaCous Chief Technology Officer 1962
Mr. James David Sullivan Sr. VP of Strategy & Compliance and Chief Legal Officer 1967
Mr. Kwok Fong Wong MD of Hong Kong & Vice-Chairman 1963
Ms. Cecilia C. Welch Chief Financial Officer 1960
Mr. Frederick Corsentino Chief Revenue Officer NA
Mr. Akintunde Carlton Jeje Managing Director of Africa NA
Mr. Alex Rocha Managing Director of EMEA NA
Mr. Mark Cochran Pres of PortalGuard NA
Mr. Kwok Fong Wong MD of Hong Kong & Vice-Chairman of the Board 1963

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.